» Authors » Koji Miyanishi

Koji Miyanishi

Explore the profile of Koji Miyanishi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 136
Citations 1695
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Osuga T, Kubo T, Miyanishi K, Ito R, Sugawara T, Ohnuma H, et al.
Intern Med . 2025 Jan; PMID: 39756877
A 65-year-old man with hepatocellular carcinoma and lung metastasis was treated with a combination of atezolizumab and bevacizumab. Subsequently, the patient developed fever and new liver lesions, which were considered...
2.
Osuga T, Tanaka S, Kubo T, Hamaguchi K, Ito R, Sakurada A, et al.
Case Rep Oncol . 2024 Mar; 17(1):407-416. PMID: 38435446
Introduction: Single distant metastases after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) are rare. There are no guidelines for treating patients without liver tumors after resecting lung metastases. Case Presentation:...
3.
Valenti L, Corradini E, Adams L, Aigner E, Alqahtani S, Arrese M, et al.
Nat Rev Endocrinol . 2023 Dec; 20(3):185. PMID: 38097672
No abstract available.
4.
Murase K, Takada K, Arihara Y, Miyanishi K, Kato J
Cureus . 2023 Aug; 15(7):e41486. PMID: 37551219
Patients with hematologic malignancies are well known to have prolonged COVID-19 pneumonia. The cause has been reported to be B cell depletion after administration of anti-CD20 antibodies. Here, we report...
5.
Valenti L, Corradini E, Adams L, Aigner E, Alqahtani S, Arrese M, et al.
Nat Rev Endocrinol . 2023 Feb; 19(5):299-310. PMID: 36805052
Hyperferritinaemia is a common laboratory finding that is often associated with metabolic dysfunction and fatty liver. Metabolic hyperferritinaemia reflects alterations in iron metabolism that facilitate iron accumulation in the body...
6.
Ito R, Miyanishi K, Kubo T, Hamaguchi K, Osuga T, Tanaka S, et al.
Hepatol Int . 2023 Feb; 17(3):735-744. PMID: 36738397
Background: Histone deacetylase (HDAC) class I and IIa are highly expressed in hepatocellular carcinoma (HCC) and associated with decreased survival. However, clinically used pan and class I inhibitors have serious...
7.
Usami M, Takada K, Nakamura H, Murase K, Arihara Y, Hayasaka N, et al.
Ann Palliat Med . 2022 Oct; 12(1):205-211. PMID: 36226651
Background: Uterine leiomyosarcoma (U-LMS) is an aggressive malignancy linked to a high risk of metastasis to distant major organs. Although cardiac metastasis of U-LMS is extremely rare, it is often...
8.
Ishinuki T, Ota S, Harada K, Kawamoto M, Meguro M, Kutomi G, et al.
World J Gastroenterol . 2022 Sep; 28(31):4442-4455. PMID: 36159009
Background: Health utility assessments have been developed for various conditions, including chronic liver disease. Health utility scores are required for socio-economic evaluations, which can aid the distribution of national budgets....
9.
Hamaguchi K, Miyanishi K, Osuga T, Tanaka S, Ito R, Sakamoto H, et al.
Cancers (Basel) . 2022 May; 14(9). PMID: 35565198
We investigated the association between iron overload, oxidative stress (8-oxo-7,8-dihydroguanine: 8-oxo-dG scores), Wnt/β-catenin pathway activation (expression of glutamine synthetase: GS), and tumor hyperintensity in the Gd-EOB-DTPA-enhanced MRI hepatobiliary phase (relative...
10.
Osuga T, Miyanishi K, Ito R, Tanaka S, Hamaguchi K, Ohnuma H, et al.
Case Rep Oncol . 2022 May; 15(1):318-325. PMID: 35529291
A 77-year-old man was referred to our hospital because of a hepatic tumor. Blood biochemistry showed elevated serum alfa-fetoprotein, protein induced by vitamin K absence-II, and carbohydrate antigen 19-9 levels....